Indraprastha Medical Corporation Ltd.
INDRAMEDCO Competitor Analysis
INDRAMEDCO | MAXHEALTH | APOLLOHOSP | FORTIS | NH | |
---|---|---|---|---|---|
Overview | |||||
Current price (₹) As on 30 Sept, 2025, 03:51 PM | 444.80 0.62% | 1,114.70 0.24% | 7,409.00 -0.47% | 969.80 -0.1% | 1,737.60 -1.99% |
Market cap (₹ Cr) | 4,078 | 1,08,365 | 1,06,530 | 73,216 | 35,510 |
Report Card | |||||
Quality | |||||
Growth | |||||
Momentum | |||||
Value | |||||
Past ReturnsAbsolute Returns Shown | |||||
1D | -1.07% | -1.01% | -0.88% | 4.07% | 2.77% |
1W | -4.31% | -3.89% | -3.12% | 0.32% | 2.28% |
1M | 0.69% | -3.66% | -2.18% | 6.5% | 1.08% |
3M | -8.92% | -12.85% | 2.79% | 22.18% | -18.32% |
6M | 14.49% | 1.37% | 12.51% | 39.01% | 4.77% |
1Y | 3.42% | 12.81% | 3.4% | 57.82% | 41.7% |
5Y | 781.46% | 864.02% | 246.55% | 617.48% | 395.2% |
Income StatementAnnual data as on 30 Sept 2025. All values in ₹ Cr. YoY growth displayed | |||||
Sales | 1,356 8.92% | 7,028 30% | 21,794 14.35% | 7,783 12.91% | 5,483 9.27% |
OPM (%) | 17.71 15.53% | 25.73 -3.71% | 13.74 10.18% | 20.23 10.61% | 22.89 1.19% |
PBT | 216.32 30.23% | 1,406 3% | 2,006 47.18% | 995.52 17.33% | 935.54 5.29% |
PAT | 160.99 29.87% | 1,076 1.7% | 1,472 60.52% | 797.86 25.51% | 790.63 0.13% |
Net Profit Margin | 11.87 19.18% | 15.31 -21.73% | 6.91 40.73% | 10.4 11.11% | 14.42 -8.39% |
EPS | 17.56 29.88% | 11.07 1.75% | 100.56 60.92% | 10.26 29.38% | 38.66 0.1% |
Balance Sheet & Cash FlowAnnual data as on 30 Sept 2025. All values in ₹ Cr. YoY growth displayed | |||||
Net Worth | 596.68 24.89% | 9,381 12.47% | 8,212 18.41% | 8,917 16.39% | 3,624 25.66% |
Total Assets | 851.62 17.75% | 15,214 26.78% | 20,657 23.3% | 13,692 3.03% | 7,265 29.16% |
Total Outside Liabilities | 254.94 3.85% | 5,834 59.44% | 12,445 26.76% | 4,775 -15.16% | 3,641 32.83% |
Cash from Operating Activity | 156.75 -21.68% | 1,459 30.04% | 2,136 11.25% | 1,424 29.45% | 985.78 -7.61% |
Cash from Investment Activity | -110.99 29.94% | -1,632 -27% | -3,381 -119.97% | -779.38 12.07% | -1,325 9.12% |
Cash from Financing Activity | -45.88 -41.69% | -163.8 37.89% | 1,317 523.2% | -713.85 -725.64% | 544.31 11.44% |
Net Cash Flow | -0.12 -101.28% | -318.6 19.24% | 72.6 0.83% | -69.76 -156.02% | 205.42 111.45% |
RatiosAnnual data as on 30 Sept 2025. | |||||
PB | 5.93 | 11.37 | 11.60 | 5.91 | 9.54 |
PE | 24.32 | 100.72 | 73.68 | 94.57 | 44.94 |
ROE (%) | 29.97 | 12.14 | 19.44 | 9.63 | 24.30 |
Dividend Yield (%) | 1.01 | 0.13 | 0.26 | 0.10 | 0.26 |
ROCE (%) | 41.43 | 15.40 | 20.90 | 12.93 | 21.45 |